The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Injectable Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Injectable Targeted Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Injectable Targeted Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, and Amgen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Injectable Targeted Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
Market segment by Application, can be divided into
Hospitals
Homecare
Specialty Clinics
Others
Market segment by players, this report covers
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Injectable Targeted Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Injectable Targeted Therapy, with revenue, gross margin and global market share of Injectable Targeted Therapy from 2019 to 2022.
Chapter 3, the Injectable Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Injectable Targeted Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Injectable Targeted Therapy research findings and conclusion, appendix and data source.
Geographical Area
Global
The Injectable Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Injectable Targeted Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Injectable Targeted Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, and Amgen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Injectable Targeted Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others
Market segment by Application, can be divided into
Hospitals
Homecare
Specialty Clinics
Others
Market segment by players, this report covers
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Injectable Targeted Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Injectable Targeted Therapy, with revenue, gross margin and global market share of Injectable Targeted Therapy from 2019 to 2022.
Chapter 3, the Injectable Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Injectable Targeted Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Injectable Targeted Therapy research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Injectable Targeted Therapy
1.2 Classification of Injectable Targeted Therapy by Type
1.2.1 Overview: Global Injectable Targeted Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Injectable Targeted Therapy Revenue Market Share by Type in 2021
1.2.3 Monoclonal Antibodies
1.2.4 Small-Molecules
1.2.5 Immunotoxins
1.2.6 Others
1.3 Global Injectable Targeted Therapy Market by Application
1.3.1 Overview: Global Injectable Targeted Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Injectable Targeted Therapy Market Size & Forecast
1.5 Global Injectable Targeted Therapy Market Size and Forecast by Region
1.5.1 Global Injectable Targeted Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Injectable Targeted Therapy Market Size by Region, (2017-2022)
1.5.3 North America Injectable Targeted Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Injectable Targeted Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Injectable Targeted Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Injectable Targeted Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Injectable Targeted Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Injectable Targeted Therapy Market Drivers
1.6.2 Injectable Targeted Therapy Market Restraints
1.6.3 Injectable Targeted Therapy Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Injectable Targeted Therapy Product and Solutions
2.1.4 Novartis Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Injectable Targeted Therapy Product and Solutions
2.2.4 Sanofi Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Injectable Targeted Therapy Product and Solutions
2.3.4 GSK Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GSK Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Injectable Targeted Therapy Product and Solutions
2.4.4 Bayer Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Injectable Targeted Therapy Product and Solutions
2.5.4 Amgen Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Amgen Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Injectable Targeted Therapy Product and Solutions
2.6.4 Merck Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Merck Recent Developments and Future Plans
2.7 AbbiVie
2.7.1 AbbiVie Details
2.7.2 AbbiVie Major Business
2.7.3 AbbiVie Injectable Targeted Therapy Product and Solutions
2.7.4 AbbiVie Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 AbbiVie Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Injectable Targeted Therapy Product and Solutions
2.8.4 AstraZeneca Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Injectable Targeted Therapy Product and Solutions
2.9.4 Teva Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Teva Recent Developments and Future Plans
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Injectable Targeted Therapy Product and Solutions
2.10.4 Roche Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Roche Recent Developments and Future Plans
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Injectable Targeted Therapy Product and Solutions
2.11.4 Pfizer Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Injectable Targeted Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Injectable Targeted Therapy Players Market Share in 2021
3.2.2 Top 10 Injectable Targeted Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Injectable Targeted Therapy Players Head Office, Products and Services Provided
3.4 Injectable Targeted Therapy Mergers & Acquisitions
3.5 Injectable Targeted Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Injectable Targeted Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Injectable Targeted Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Injectable Targeted Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Injectable Targeted Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Injectable Targeted Therapy Revenue by Type (2017-2028)
6.2 North America Injectable Targeted Therapy Revenue by Application (2017-2028)
6.3 North America Injectable Targeted Therapy Market Size by Country
6.3.1 North America Injectable Targeted Therapy Revenue by Country (2017-2028)
6.3.2 United States Injectable Targeted Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Injectable Targeted Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Injectable Targeted Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Injectable Targeted Therapy Revenue by Type (2017-2028)
7.2 Europe Injectable Targeted Therapy Revenue by Application (2017-2028)
7.3 Europe Injectable Targeted Therapy Market Size by Country
7.3.1 Europe Injectable Targeted Therapy Revenue by Country (2017-2028)
7.3.2 Germany Injectable Targeted Therapy Market Size and Forecast (2017-2028)
7.3.3 France Injectable Targeted Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Injectable Targeted Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Injectable Targeted Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Injectable Targeted Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Injectable Targeted Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Injectable Targeted Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Region
8.3.1 Asia-Pacific Injectable Targeted Therapy Revenue by Region (2017-2028)
8.3.2 China Injectable Targeted Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Injectable Targeted Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Injectable Targeted Therapy Market Size and Forecast (2017-2028)
8.3.5 India Injectable Targeted Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Injectable Targeted Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Injectable Targeted Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Injectable Targeted Therapy Revenue by Type (2017-2028)
9.2 South America Injectable Targeted Therapy Revenue by Application (2017-2028)
9.3 South America Injectable Targeted Therapy Market Size by Country
9.3.1 South America Injectable Targeted Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Injectable Targeted Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Injectable Targeted Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Injectable Targeted Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Injectable Targeted Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Country
10.3.1 Middle East & Africa Injectable Targeted Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Injectable Targeted Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Injectable Targeted Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Injectable Targeted Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Injectable Targeted Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Injectable Targeted Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Injectable Targeted Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Injectable Targeted Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Injectable Targeted Therapy Revenue Market Share by Region (2023-2028)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Injectable Targeted Therapy Product and Solutions
Table 9. Novartis Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Injectable Targeted Therapy Product and Solutions
Table 13. Sanofi Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GSK Corporate Information, Head Office, and Major Competitors
Table 15. GSK Major Business
Table 16. GSK Injectable Targeted Therapy Product and Solutions
Table 17. GSK Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Injectable Targeted Therapy Product and Solutions
Table 21. Bayer Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Amgen Corporate Information, Head Office, and Major Competitors
Table 23. Amgen Major Business
Table 24. Amgen Injectable Targeted Therapy Product and Solutions
Table 25. Amgen Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck Injectable Targeted Therapy Product and Solutions
Table 29. Merck Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. AbbiVie Corporate Information, Head Office, and Major Competitors
Table 31. AbbiVie Major Business
Table 32. AbbiVie Injectable Targeted Therapy Product and Solutions
Table 33. AbbiVie Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 35. AstraZeneca Major Business
Table 36. AstraZeneca Injectable Targeted Therapy Product and Solutions
Table 37. AstraZeneca Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Teva Corporate Information, Head Office, and Major Competitors
Table 39. Teva Major Business
Table 40. Teva Injectable Targeted Therapy Product and Solutions
Table 41. Teva Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Roche Corporate Information, Head Office, and Major Competitors
Table 43. Roche Major Business
Table 44. Roche Injectable Targeted Therapy Product and Solutions
Table 45. Roche Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Pfizer Corporate Information, Head Office, and Major Competitors
Table 47. Pfizer Major Business
Table 48. Pfizer Injectable Targeted Therapy Product and Solutions
Table 49. Pfizer Injectable Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Injectable Targeted Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Injectable Targeted Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Injectable Targeted Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Injectable Targeted Therapy Players Head Office, Products and Services Provided
Table 54. Injectable Targeted Therapy Mergers & Acquisitions in the Past Five Years
Table 55. Injectable Targeted Therapy New Entrants and Expansion Plans
Table 56. Global Injectable Targeted Therapy Revenue (USD Million) by Type (2017-2022)
Table 57. Global Injectable Targeted Therapy Revenue Share by Type (2017-2022)
Table 58. Global Injectable Targeted Therapy Revenue Forecast by Type (2023-2028)
Table 59. Global Injectable Targeted Therapy Revenue by Application (2017-2022)
Table 60. Global Injectable Targeted Therapy Revenue Forecast by Application (2023-2028)
Table 61. North America Injectable Targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Injectable Targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Injectable Targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Injectable Targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Injectable Targeted Therapy Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Injectable Targeted Therapy Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Injectable Targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Injectable Targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Injectable Targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Injectable Targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Injectable Targeted Therapy Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Injectable Targeted Therapy Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Injectable Targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Injectable Targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Injectable Targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Injectable Targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Injectable Targeted Therapy Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Injectable Targeted Therapy Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Injectable Targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Injectable Targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Injectable Targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Injectable Targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Injectable Targeted Therapy Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Injectable Targeted Therapy Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Injectable Targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Injectable Targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Injectable Targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Injectable Targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Injectable Targeted Therapy Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Injectable Targeted Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Injectable Targeted Therapy Picture
Figure 2. Global Injectable Targeted Therapy Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibodies
Figure 4. Small-Molecules
Figure 5. Immunotoxins
Figure 6. Others
Figure 7. Injectable Targeted Therapy Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Homecare Picture
Figure 10. Specialty Clinics Picture
Figure 11. Others Picture
Figure 12. Global Injectable Targeted Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Injectable Targeted Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Injectable Targeted Therapy Revenue Market Share by Region (2017-2028)
Figure 15. Global Injectable Targeted Therapy Revenue Market Share by Region in 2021
Figure 16. North America Injectable Targeted Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Injectable Targeted Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Injectable Targeted Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Injectable Targeted Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Injectable Targeted Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Injectable Targeted Therapy Market Drivers
Figure 22. Injectable Targeted Therapy Market Restraints
Figure 23. Injectable Targeted Therapy Market Trends
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. GSK Recent Developments and Future Plans
Figure 27. Bayer Recent Developments and Future Plans
Figure 28. Amgen Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. AbbiVie Recent Developments and Future Plans
Figure 31. AstraZeneca Recent Developments and Future Plans
Figure 32. Teva Recent Developments and Future Plans
Figure 33. Roche Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. Global Injectable Targeted Therapy Revenue Share by Players in 2021
Figure 36. Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Injectable Targeted Therapy Revenue Market Share in 2021
Figure 38. Global Top 10 Players Injectable Targeted Therapy Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Injectable Targeted Therapy Revenue Share by Type in 2021
Figure 41. Global Injectable Targeted Therapy Market Share Forecast by Type (2023-2028)
Figure 42. Global Injectable Targeted Therapy Revenue Share by Application in 2021
Figure 43. Global Injectable Targeted Therapy Market Share Forecast by Application (2023-2028)
Figure 44. North America Injectable Targeted Therapy Sales Market Share by Type (2017-2028)
Figure 45. North America Injectable Targeted Therapy Sales Market Share by Application (2017-2028)
Figure 46. North America Injectable Targeted Therapy Revenue Market Share by Country (2017-2028)
Figure 47. United States Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Injectable Targeted Therapy Sales Market Share by Type (2017-2028)
Figure 51. Europe Injectable Targeted Therapy Sales Market Share by Application (2017-2028)
Figure 52. Europe Injectable Targeted Therapy Revenue Market Share by Country (2017-2028)
Figure 53. Germany Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Injectable Targeted Therapy Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Injectable Targeted Therapy Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Injectable Targeted Therapy Revenue Market Share by Region (2017-2028)
Figure 61. China Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Injectable Targeted Therapy Sales Market Share by Type (2017-2028)
Figure 68. South America Injectable Targeted Therapy Sales Market Share by Application (2017-2028)
Figure 69. South America Injectable Targeted Therapy Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Injectable Targeted Therapy Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Injectable Targeted Therapy Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Injectable Targeted Therapy Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Injectable Targeted Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
